:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fevidation-wordmark-black-cmyk.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Fkate-binghama-banner.jpg)
SV Health Investors Announces Licensing and Research Collaboration between Sitryx and Lilly to Discover and Develop New Immunometabolic Medicines
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FSutro-Biopharma-Logo.png){kind=logo}
- 29 May 2020Portfolio NewsDeciphera Pharmaceuticals Announces Presentations of Positive Patient Reported Outcomes Results from INVICTUS Phase 3 Study of QINLOCKTM (ripretinib) in Patients with Fourth-Line Advanced GIST at the ASCO 2020 Virtual Scientific Program
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FSutro-Biopharma-Logo.png)
21 May 2020Portfolio NewsSutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller- 13 May 2020Portfolio NewsAVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCatabasis-logo.png)
12 May 2020Portfolio NewsCatabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress- 12 May 2020Portfolio NewsBicycle Therapeutics Announces Publication of BT5528 Mechanism of Action in AACR Journal Molecular Cancer Therapeutics
- 6 May 2020Portfolio NewsAVROBIO and Magenta Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
- 5 May 2020Portfolio NewsBicycle Therapeutics Announces First Patient Dosed in Phase I Dose Escalation of BT5528 in Combination with Nivolumab
- 4 May 2020Portfolio NewsAVROBIO to Collaborate with Saladax Biomedical on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2Fkate-binghama-banner.jpg)
1 May 2020SV NewsHow the UK life sciences industry is rising to the challenge of Covid-19 by Kate Bingham
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Flogo_karustx.png)
28 April 2020Portfolio NewsKarus Therapeutics Announces New Data from Phase I Cancer Trial at AACR
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FXilio-logo.png)
27 April 2020Portfolio NewsXilio Therapeutics Appoints Martin H. Huber, M.D. as Chief Medical Officer to lead XTX201 (tumor-selective IL-2) and XTX101 (tumor-Selective aCTLA-4) into the clinic while xilio continues to advance its tumor-selective cytokine pipeline- 27 April 2020Portfolio NewsSutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer